Search

Your search keyword '"Laabidi S"' showing total 107 results
Start Over Author "Laabidi S"
107 results on '"Laabidi S"'

22. Treatment adherence and insight in schizophrenia spectrum disorders.

Author

Laabidi, S., Abidi, O., Aissa, A., Hosni, R., Ouali, U., and Jomli, R.

Subjects
*PATIENT compliance, *SCHIZOPHRENIA, *SOCIAL impact, *ANTIPSYCHOTIC agents, *PEOPLE with schizophrenia
Abstract

Introduction: Lack of adherence to antipsychotic medication in patients with schizophrenia spectrum disorders is a major risk factor for relapse and rehospitalizations which contributes to major social and economic consequences. A high proportion of patients with schizophrenia are partially or completely unaware of their mental disorder. Objectives: The aim of this study was to investigate the association between insight and medication adherence. Methods: A total number of 30 outpatients with schizophrenia spectrum disorders ,according to (DSM-V) diagnostic criteria who were attending the department of psychiatry A Razi hospital between august and September 30, 2023 were included in this study. Patients' insight was measured by the birchwood insight scale. The degree of medication adherence was measured by using Medication Adherence Rating Scale (MARS). Results: Patients enrolled in the study had a mean (SD) age of 43.2.There was no significant correlation between patients' insight and patients' ages, duration of illness and hospitalization times. In addition, there was no significant association between medication adherence and age, duration of illness, number of hospitalization or social level. Impaired insight was associated with poor antipsychotic medication adherence in patients with schizophrenia spectrum disorders.Higher insight was correlated to higher therapeutic adherence. Our results showed that the level of insight and compliance to treatment are positively correlated. Conclusions: The results of this study support the hypothesis that insight and treatment adherence are closely related. Interventions to enhance insight may be helpful in improving medication adherence. Disclosure of Interest: None Declared [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Is treatment adherence linked to self-compassion in schizophrenia?

Author

Laabidi, S., Abidi, O., Aissa, A., Hosni, R., Ouali, U., and Jomli, R.

Subjects
*COGNITIVE therapy, *SCHIZOPHRENIA, *PATIENT compliance, *SELF-compassion, *SCHIZOAFFECTIVE disorders
Abstract

Introduction: Self-compassion is defined as the ability to be open to and touched by one's suffering and to relate to it with kindness and non-judgmental awareness. Although identifying factors related to treatment adherence remains an important challenge in patients with schizophrenia spectrum disorders, self-compassion has rarely been investigated in this population. Further studies are needed to investigate whether self-compassion training can improve treatment adherence in this population. Objectives: The objective of the present study was to investigate the relationship between self-compassion and treatment adherence in patients with schizophrenia spectrum disorders. Methods: thirty stabilized adult outpatients with schizophrenia (n=18), schizoaffective disorder (n=11), brief psychotic disorder (n=1) per DSM-5 criteria were included. Self- compassion was assessed using the 26-item Self-Compassion Scale (SCS). Treatment adherence was assessed using the Medical Adherence Rating Scale (MARS). Socio- demographic characteristics, including age, gender, academic level, and mean daily antipsychotic dosages were collected. Results: There was no significant difference in SCS scores and MARS scores as a function of gender, age, or academic level. The results of the present preliminary study suggest a positive correlation between the SCS total scores and the MARS scores. It was found that higher levels of self-compassion are related with higher levels of treatment adherence in patients with schizophrenia spectrum disorders and lower levels of self- compassion are associated with discontinuation of medications without a psychiatrist's recommendation. This connection was present in all diagnostic groups. Conclusions: The results of the present preliminary study suggest that self-compassion and treatment adherence are closely related. Improving self-compassion in patients with schizophrenia spectrum disorders may improve their level of treatment adherence. Further studies are needed to investigate whether self-compassion training programs could be useful as an extension of standard psychoeducation and cognitive behavioral therapy to improve treatment adherence in this population. Disclosure of Interest: None Declared [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Connection between self-esteem and discontinuation of medication.

Author

Laabidi, S., Abidi, O., Aissa, A., Hosni, R., Ouali, U., and Jomli, R.

Subjects
*PATIENT compliance, *COGNITIVE therapy, *SCHIZOPHRENIA, *PEOPLE with mental illness, *SCHIZOAFFECTIVE disorders
Abstract

Introduction: Self-esteem entails evaluating oneself positively and often involves the need to be special and above average without comparisons with others. It could play a role in many areas of the patient's life. Objectives: The aim of the present study was to find the prevalence of self-esteem and investigate the associations between self-esteem and treatment adherence in patients with schizophrenia spectrum disorders. Methods: This study involved outpatients with schizophrenia spectrum disorders ,according to (DSM-V) diagnostic criteria, attending the Department of Psychiatry A, Razi hospital between august and September 30, 2023. The level of self-esteem was measured with Rosenberg's Self-Esteem Rating scale (SERS) and treatment adherence with the Medical Adherence Rating Scale (MARS).Socio-demographic characteristics were also collected. Results: Thirty stabilized outpatients with schizophrenia (n=18), schizoaffective disorder (n=11), brief psychotic disorder (n=1) were included in the study. The mean (SD) age of the respondents was 43.2years; the mean number of Hospital admissions was 4.7.Almost two thirds of this population (63.33%) had low self-esteem and 36.67 % had high self-esteem. The level of self-esteem did not differ between diagnostic categories. Self-esteem also positively correlated with higher education and negatively with an increased number of hospitalizations. However, no significant association was found between socio-demographic variables and self-esteem. Adherence was further negatively correlated with age and age of onset of disorders. Patients suffering from schizophrenia had the lowest adherence to treatment.The results of the present preliminary study suggest a positive correlation between the SERS total scores and the MARS scores. It was found that higher levels of self- esteem are related with higher levels of treatment adherence and lower levels of self- esteem are associated with discontinuation of medications without a psychiatrist's recommendation. This connection was present in all diagnostic groups. Conclusions: This study shows positive relationship between self-esteem and treatment adherence. Further studies are needed to investigate whether self-esteem is a factor positively influencing adherence to treatment and show if self-esteem training programs like standard psychoeducation and cognitive behavioral therapy could be beneficial to improve treatment adherence among psychiatric patients. Disclosure of Interest: None Declared [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Esophagogastric junction outflow obstruction: is it an early stage of achalasia?

Author

Labidi, A., Oumaima, M., Zouiten, L., Mustapha, N. Ben, Laabidi, S., Meriem, S., Fekih, M., and Boubaker, J.

Subjects
ESOPHAGOGASTRIC junction, ESOPHAGEAL achalasia, ESOPHAGEAL motility, TELEPHONE calls
Abstract

This article examines the clinical and paraclinical aspects of esophagogastric junction outflow obstruction (EGJOO) and compares them to achalasia, a condition characterized by dysregulated esophageal motility. The study collected data from 70 patients, with 59 diagnosed with achalasia and 11 diagnosed with EGJOO. The findings suggest that while EGJOO and achalasia share symptomatic similarities, they may represent distinct entities rather than an early stage of achalasia. Further research is needed to better understand these conditions and develop tailored therapeutic approaches. [Extracted from the article]

Published
2024
Full Text
View/download PDF

26. Polypectomie colique: critères de qualité

Author

Laabidi, S, additional, Said, Y, additional, Trad, N, additional, Mensi, A, additional, Soua, S, additional, El Jeri, K, additional, Zaimi, Y, additional, Ayadi, S, additional, Mouelhi, L, additional, and Debbeche, R, additional

Published
2019
Full Text
View/download PDF

29. PUB003 Metastases in T1-T2 classed Lung Cancer

Author

Neji, H., primary, Ouji, R., additional, Attia, M., additional, Gharsalli, H., additional, Laabidi, S., additional, Baccouche, I., additional, Mekkaoui, A., additional, Hantous-Zannad, S., additional, and Ben Miled-M'Rad, K., additional

Published
2017
Full Text
View/download PDF

32. The major prognostic factors of thymomas: about a Tunisian study of 100 cases

Author

Mona Mlika, Boudaya, M. S., Laabidi, S., Zaimi, Y., Smadhi, H., Marghli, A., El-Mezni, F., and Kilani, T.

Subjects
Male, Time Factors, Tunisia, Thymoma, Biopsy, Reproducibility of Results, Kaplan-Meier Estimate, Thymus Neoplasms, Thymectomy, Neoadjuvant Therapy, Tumor Burden, Treatment Outcome, Predictive Value of Tests, Humans, Female, Tomography, X-Ray Computed, Neoplasm Staging, Retrospective Studies
Abstract

Thymomas are characterised by their rarity, histologic variability and peculiar patterns of recurrence. Herein, we present the experience of a single institution and aim to highlight the major prognostic factors of these tumours.We present a retrospective study on 100 thymomas diagnosed between 1994 and 2011. Statistical analyses were performed using version 18.0 SPSS. The Kaplan Meier method was used to estimate survival, and survival curves were compared using the Log-Rank test. A p0.05 was considered statistically significant.50 men and 50 women underwent surgical resection for thymoma. Radiologic findings highlighted a diagnosis of thymoma in 51% of cases. The thymomas were classified as stage I in 25 cases, stage II in 47 cases, stage III in 25 cases and stage IV in 3 cases. According to the WHO classification, tumours were classified as type A in 14 cases, type AB in 24 cases, type B1 in 17 cases, type B2 in 20 cases, type B3 in 8 cases, B1/B2 in 8 cases and B2/B3 in 9 cases. The mean survival of patients was 136 months. Age, sex, tumour size, WHO classification and Masaoka stage were evaluated as prognostic factors. Univariate analysis showed that the major prognostic factors were WHO classification (p = 0.019) and Masaoka Stage (p = 0.0001).Our results place emphasis on the prognostic value of WHO classification and Masaoka stage in thymomas; in addition, the necessity of improving reproducibility of microscopic classification to avoid discrepancies among prognostic groups is highlighted.

Published
2015

36. Breast cancer in the elderly

Author

Nasr⁎, S. Ben, primary, Bahloul, R., additional, Noubbigh, G.E.F., additional, Mokrani, A., additional, Ayadi, M.M., additional, Afrit, M., additional, Laabidi, S., additional, and Boussen, H., additional

Published
2012
Full Text
View/download PDF

40. Near-infrared spectrometry in pregnancy: progress and perspectives, a review of literature

Author

Anouar Jarraya, Smaoui Mohamed, Laabidi Sofiene, and Kamel Kolsi

Subjects
near-infrared spectrometry, pregnancy, preeclamsia, cesarean section, Medicine
Abstract

Near-infrared spectroscopy (NIRS) allows continuous noninvasive monitoring of in vivo oxygenation in selected tissues. It has been used primarily as a research tool for several years, but it is seeing wider application in the clinical arena all over the world. It was recently used to monitor brain circulation in cardiac surgery , carotid endarteriectomy , neurosurgery and robotic surgery. According to the few studies used NIRS in pregnancy, it may be helpful to assess the impact of severe forms of preeclampsia on brain circulation, to evaluate the efficacy of different treatments. It may also be used during cesarean section to detect earlier sudden complications. The evaluation of placental function via abdominal maternal approach to detect fetal growth restriction is a new field of application of NIRS.

Published
2016
Full Text
View/download PDF

41. Metastatic bladder cancer.

Author

Khrouf. S., Daoud. N., El Benna. H., Mejri. N., Laabidi. S., and Boussen. H.

Subjects
METASTASIS, LIVER metastasis, ADJUVANT treatment of cancer, UNIVARIATE analysis, BLADDER cancer, CANCER patients
Abstract

OBJECTIVE To report the epidemiolgical, anatomo-clinical features, treatment and therapeutic results in metastatic bladder cancer in Tunisian patients. PATIENTS AND METHODS Our retrospective study concerned patients presenting a metastatic (synchronous or metachronous) bladder cancer treated in our department. We collected the data concerning epidemiological, anatomo-clinical features, treatment and therapeutic results. RESULTS We collected 21 patients from 2011 to 2018, having a mean age of 64 years (42 to 85) and a 9 sex-ratio. They have 72% of metachronous and 28% of synchronous metastases with a mean time of 10 months after surgery. Surgery was performed 14/21(66%) were operated and only 28% (4/14) received adjuvant chemotherapy performed with mean time of 56 days.4 patients recei ved a neoadjuvant treatment followed by radiotherapy in 3 cases. Metastatic sites were bones and lungs in 51% and 48%, liver in 24% of cases. 44% of patients required opioids for pain in. 1st line chemotherapy consisted for 89% of patients, mostly with gemcitabin-cisplatin (27%), gemcitabin-carboplatin (27%), of monotherapy in 13% of cases. Treatment was complicated by renal in 10% and hematologic toxicity in 24% of cases. We observed 34% objectives response-stable disease. 17% of patients received a 2nd line chemotherapy with monotherapy, in a mean number of cycles of 3 and 62% of them progressed under therapy. 37% received a 3rd line treatment. With a median follow-up of21 months, median survival was 8months for synchronous metastases and 15 months after initial diagnosis. Univariate analysis showed significance of hemoglobin cut-off at 10g/l (13 versus 7 months, p=0.008) and liver metastases(13 versus 7 months, p=0.04). CONCLUSION Metastatic bladder cancer is a poor-prognosis disease requiring a heavy treatment, frequentlyburdened by the initial patient's general status. [ABSTRACT FROM AUTHOR]

Published
2019

42. Localized bladder cancer: Retrospective study about 37 cases.

Author

Khrouf. S., Daoud. N., El Benna. H., Mejri. N., Laabidi. S., and Boussen. H.

Subjects
TUMOR classification, ADJUVANT treatment of cancer, RETROSPECTIVE studies, BLADDER cancer, CANCER patients, UROLOGISTS
Abstract

OBJECTIVE To report the epidemiolgical, anatomo-clinical features, treatment and therapeutic results in localized bladder cancer in Tunisian patients. PATIENTS AND METHODS Our retrospective study concerned patients presenting a localized bladder cancer treated in our department. We collected the data concerning epidemiological, anatomo-clinical features, treatment and therapeutic results. RESULTS We collected 37 patients from 2011 to 2018, having a mean age of 64 years (42 to 85) and 9 sex-ratio. Tumor were at stages pT2 in 45% of cases and pT1 in 13.5% and missed for the other patients. On histology, tumors were of high grade in 59% of cases and N+ in imagery with presence of an urothelial carcinomain 70% of endoscopic samples.8/37 patients received a neoadjuvant chemotherapy mostly with carboplatin and gemcitabin and a mean number of cycles of 3. On the 7 evaluated patients, we observed 4 objectives responses and 3 stable disease. 4 patients received adjuvant radiotherapy. Primary surgery concerned 22pts (59,5%), 6 (16,2%) received adjuvant radiotherapy and 4(10.8%). Adjuvant chemotherapy was administered to 13 patients (35%). Protocols consisted in MVAC-HDin 1 patient, Gemzar-CDDP in 10.8% and gemcitabine-carboplatinin 18.9% of cases with a mean number of 4 cycles. With a median follow-up of 22months, median survival was 12 months CONCLUSION The treatment of bladder cancer requires a mutlidisciplinary management with urologists, medical oncologists, radiotherapists and radiologists. However most of our patients have a delayed diagnosis and locally advanced tumours. [ABSTRACT FROM AUTHOR]

Published
2019

44. Oral Communication Abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018

Author

Benna, M., Slimane, M., Smaoui, W., Syrjanen, K., Belaid, A., Bouaziz, H., Hechiche, M., Benna, F., Rahal, K., Benhami, M., El Kinany, H., Ouahbi, H., Amadour, L., Ahllali, I., Ben Brahim, Z., Elmrabet, F. Z., Arifi, S., Mellas, N., Hashem, W., Abd-Elkader, Y., Mokrani, A., Shehata, M. A., Baker El Khouly, E. A., Elkady, N. M., Yahyaoui, Y., Meddeb, K., Letaif, F., Chraiet, N., Ayadi, M., Melzi, A., Kessi Nora, N., Abdelmalik, F., Elfageih, M. A., Abdeljaoued, S., Goucha, A., El Mokh, H., Ben Hassouna, J., Gamoudi, A., Ben Rekaya, M., Yosr Hamdi, Laabidi, S., Jaidane, O., Ben Nasr, S., Elbenna, H., Mejri, N., Daoud, N., Ayari, J., Balti, M., Mighri, N., Boujemaa, M., Haddaoui, A., Boussen, H., Abdelhak, S., Mashhour, K., Safwat, E., Kouadri, N., Filali, T., Tawfik, E. A., Elagizy, H. A., Berrazaga, Y., Gabsi, A., Raies, H., Derbouz, Z., Henni Manseur, S., Bounedjar, A., Elrgig, M., Abdalla, A. B., Bettaieb, I., Adouni, O., and Bouzaiene, H.

45. Summaries of the papers of the 4th National Congress of the Tunisian Society of Medical Oncology attached to the 4th Maghreb Congress of Oncology

Author

Abbes, I., Abdelhak, S., Abdelhedi, C., Abid, K., Abidi, R., Acacha, E., Achour, S., Achour, A., Adouni, O., Afrit, M., Ahlem, A., Akik, I., Akremi, M., Aloui, R., Aloulou, S., Ammar, N., Arem, S., Athimni, S., Attia, L., Attia, M., Ayadi, M., Ayadi, A., Ayadi, K., Ayadi, H., Ayadi, L., Ayadi, I., Ayari, J., Azzouz, H., Bacha, D., Bahloul, R., Bahri, I., Bahri, M., Bakir, D., Balti, M., Bargaoui, H., Batti, R., Bayar, R., Bdioui Thabet, A., Beji, M., Bel Hadj Hassen, S., Bel Haj Ali, A., Belaid, I., Belaid, A., Beldjiilali, Y., Belkacem, O., Bellamlih, O., Ben Abdallah, W., Ben Abdallah, M., Ben Abdellah, H., Ben Abderrahmen, S., Ben Ahmed, S., Ben Ahmed, K., Ben Ayache, M., Ben Ayoub, W., Ben Azaiz, M., Ben Azouz, M., Ben Daly, A., Ben Dhia, S., Ben Dhiab, M., Ben Dhiab, T., Ben Fatma, L., Ben Ghachem, D., Ben Hammadi, S., Ben Hassen, M., Ben Hassena, R., Ben Hassouna, J., Ben Kridis, W., Ben Leila, F., Ben Mahfoudh, K. H., Ben Mustapha, N., Ben Nasr, S., Ben Othman, F., Ben Rejeb, M., Ben Rekaya, M., Sami BenRhouma, Ben Safta, Z., Ben Safta, I., Ben Said, A., Ben Salah, M., Ben Salah, H., Ben Slama, S., Ben Temime, R., Ben Youssef, Y., Ben Zid, K., Benabdella, H., Benasr, S., Bengueddach, A., Benna, M., Benna, F., Bergaoui, H., Berrazaga, Y., Besbes, M., Bhiri, H., Bibi, M., Blel, A., Bohli, M., Bouali, S., Bouaouina, N., Bouassida, K., Bouaziz, H., Boubaker, J., Boudaouara, T., Boudaouara, Z., Boudaouara, O., Boughanmi, F., Boughattas, W., Boughizane, S., Bouguila, H., Bouhani, M., Bouhlel, B., Boujelbane, N., Boujemaa, M., Boulma, R., Bouraoui, S., Bouriga, R., Bourmech, M., Bousrih, C., Boussen, H., Boussen, N., Bouzaien, F., Bouzayene, F., Brahem, I., Briki, R., Chaabene, K., Chaabouni, M., Chaari, H., Chabchoub, I., Chachia, S., Chaker, K., Chamlali, M., Charfi, L., Charfi, M., Charfi, S., Charradi, H., Cheffai, I., Chelly, B., Chelly, I., Chenguel, A., Cherif, A., Cherif, O., Chiboub, A., Chouchene, A., Chraiet, N., Daghfous, A., Daldoul, A., Daoud, N., Daoud, J., Daoud, R., Daoud, E., Debaibi, M., Dhaouadi, S., Dhief, R., Dhouib, F., Dimassi, S., Djebbi, A., Doghri, R., Doghri, Y., Doudech, B., Dridi, M., El Amine, O., El Benna, H., El Khal, M. C., Eladeb, M., Elloumi, M., Elmeddeb, K., Enaceur, F., Ennouri, S., Essoussi, M., Ezzairi, F., Ezzine, A., Faleh, R., Fallah, S., Faouzi, N., Fathallah, K., Fehri, R., Feki, J., Fekih, M., Fendri, S., Fessi, Z., Fourati, N., Fourati, M., Frikha, I., Frikha, M., Gabsi, A., Gadria, S., Gamoudi, A., Gargoura, A., Gargouri, W., Ghariani, N., Ghazouani, E., Ghorbal, A., Ghorbel, L., Ghorbel, S., Ghozzi, A., Glili, A., Gmadh, K., Goucha, A., Gouiaa, N., Gritli, S., Guazzah, K., Guebsi, A., Guermazi, Z., Guermazi, F., Gueryani, N., Guezguez, M., Hacheni, F., Hachicha, M., Haddad, A., Haddaoui, A., Hadoussa, M., Haj Mansour, M., Hajjaji, A., Hajji, A., Hamdi, A., Hamdi, Y., Hammemi, R., Haouet, S., Hdiji, A., Hechiche, M., Hedfi, M., Helali, A. J., Henchiri, H., Heni, S., Hentati, A., Herbegue, K., Hidar, S., Hlaf, M., Hmida, W., Hmida, I., Hmida, L., Hmila Ben Salem, I., Hochlef, M., Hsairi, M., Jaffel, H., Jaidane, M., Jarraya, H., Jebsi, M., Jedidi, M., Jlassi, A., Jlassi, H., Jmal, H., Jmour, O., Jouini, M., Kabtni, W., Kacem, M., Kacem, S., Kacem, I., Kaid, M., Kairi, H., Kallel, M., Kallel, R., Kallel, F., Kammoun, H., Kamoun, S., Kanoun Belajouza, S., Karray, W., Karrit, S., Karrou, M., Kchir, N., Kdous, S., Kehili, H., Keskes, H., Khairi, H., Khalfallah, M. T., Khalifa, M. B., Khanfir, A., Khanfir, F., Khechine, W., Khemiri, S., Khiari, H., Khlif, A., Khouni, H., Khrouf, S., Kochbati, L., Korbi, I., Korbi, A., Krir, M. W., Ksaier, I., Ksantini, R., Ksantini, M., Ksantini, F., Ktari, K., Laabidi, S., Laamouri, B., Labidi, A., Lahmar, A., Lahouar, R., Lamine, O., Letaief, F., Limaiem, F., Limayem, I., Limem, S., Limem, F., Loghmari, A., M Ghirbi, F., Maamouri, F., Magherbi, H., Mahjoub, N., Mahjoub, M., Mahjoubi, K., Majdoub, S., Makhlouf, T., Makni, A., Makni, S., Mallat, N., Manai, M. H., Mansouri, H., Maoua, M., Marghli, I., Masmoudi, T., Mathlouthi, N., Meddeb, K., Medini, B., Mejri, N., Merdessi, A., Mesali, C., Mezlini, E., Mezlini, A., Mezni, E., Mghirbi, F., Mhiri, N., Mighri, N., Mlika, M., Mnejja, W., Mnif, H., Mokni, M., Mokrani, A., Mosbah, F., Moujahed, R., Mousli, A., Moussa, A., Mrad Dali, K., Mrizak, N., Msakni, I., Mzabi, S., Mzali, R., Mzoughi, Z., Naimi, Z., Najjar, S., Nakkouri, R., Nasr, C., Nasrallah, D., Nasri, M., Njim, L., Noubigh, G. E. F., Nouira, Y., Nouri, O., Omrani, S., Osmane, W., Ouanes, Y., Ouanna, N., Oubich, F., Oumelreit Belamlih, G., Rachdi, H., Rafraf, F., Rahal, K., Raies, H., Rammeh, S., Rebaii, N., Rekik, W., Rekik, H., Rhim, M. S., Rhim, S., Rihab, D., Rjiba, R., Rziga, T., Saad, H., Saad, A., Saadi, M., Said, N., Salah, R., Sallemi, N., Sassi, A., Sassi, K., Sassi Mahfoudh, A., Sbika, W., Sellami, A., Serghini, M., Sghaier, S., Sh Zidi, Y., Siala, W., Slimane, M., Slimani, O., Soltani, S., Souguir, M. K., Sridi, A., Tabet Zatla, A., Tajina, D., Talbi, G., Tbessi, S., Tebra Mrad, S., Temessek, H., Tlili, G., Toumi, N., Toumi, O., Toumia, N., Tounsi, H., Trigui, E., Triki, M., Triki, A., Turki, M., Werda, I., Yahyaoui, S., Yahyaoui, Y., Yaich, A., Yamouni, M., Yazid, D., Yousfi, A., Zaghouani, H., Zaied, S., Zairi, F., Zaraa, S., Zehani, A., Zenzri, Y., Zidi, A., Znaidi, N., Zouari, K., Zouari, S., Zoukar, O., and Zribi, A.

46. Oral communication and poster abstracts of the 22nd National Congress of Gastroenterology joint to the 4th Maghrebian Congress of Gastroenterology. December 2018

Author

Bellabah, A., Benkirane, A., Ibrahimi, A., Nakhli, A., Sair, A., Essaid, A., Blel, A., Lahchaichi, A., Ben Slama, A., Ouni, A., Amouri, A., Jemaa, A., Cherif, A., Khsiba, A., Hssine, A., Djobbi, A., Guedich, A., Laabidi, A., Mensi, A., Ouakaa, A., Sriha, A., Choukri, A., Green, A., Belkhamsa, A., Hammami, A., Bourigua, A., Filali, A., Belabeh, A., Sentissi, A., Ait Errami, A., Nadi, A., Filankembo, A., Lamine, A., Badre, W., Ben Kaab, B., Ben Slimane, B., S, B., Hasnaoui, B., Bouchabou, B., Bouguerra, C., Baccouche, C., Ayadi, C., Bennasrallah, C., Benajah, D., Gargouri, D., Zehi, D., Issaoui, D., Cherif, D., Ben Ghachem, D., Trad, D., Bouaiti, E., Boutouria, E., Bel Hadj Mabrouk, E., Chalbi, E., Aait, E., Bouhamou, F., Haddad, F., Lairani, F., Saffar, F., Torjmen, F., Haj Kacem, F., Hamdane, F., Chabib, F. Z., Elrhaoussi, F. Z., Moumayez, F. Z., Loukil, F., Ahmed Djouldé Diallo, F., Aissaoui, F., Ajana, F., Chabib, F., Hamdoun, F., Moumayez, F., Bennani Kella, G., Bennani, G., Abid, H., Cheikhani, H., Ouazzani, H., Romdhane, H., Hassan SEDDIK, Sghir, H., Debbabi, H., Ben Jeddi, H., Garraoui, H., Letaief, H., Kchir, H., Elloumi, H., Hammami, H., Jaziri, H., Ben Abdallah, H., Chaabouni, H., Ben Romdhane, H., Yacoub, H., Gdoura, H., Sahli, H., Loghmari, H., Bouguerra, H., Maghrebi, H., Ben Nejma, H., Jlassi, H., Fourati, H., Alaoui, H., Ismail, H., Benelbarhdadi, I., Cohen, I., Errabih, I., Koti, I., Doghri, I., Elhidaoui, I., Haraki, I., Cheikh, I., Abdelaali, I., Jemni, I., Bouennene, I., Akoch, I., H, I., Boubaker, J., Krati, K., Eljery, K., Temani, K., Bellil, K., Chabbouh, K., Boughoula, K., Ouazzani, L., Ben Yaghlene, L., Kallel, L., A, L., Hamzaoui, L., Chtourou, L., Ben Farhat, L., Bouabid, L., Mnif, L., Mouelhi, L., Safer, L., Zouiten Mekki, L., Bourehma, M., El Akbari, M., El Khayari, M., Elyousfi, M., Firwana, M., Lahlali, M., Tahiri, M., Mestouri, M., Abdelwahed, M., Ben Hamida, M., Ben Chaabane, M., Moalla, M., Yakoubi, M., Sabbah, M., Serghini, M., Amri, M., Ben Abbes, M., Ben Cheikh, M., Ghribi, M., Hafi, M., Ben Abdelwahed, M., Ksiaa, M., Essid, M., Zakhama, M., Yousfi, M., Ayari, M., Belhadj, M., Cheickh, M., Kacem, M., Horma Alaoui, M., Abid, M., Bennour, M. A., Ghanem, M., Loghmari, M. H., Douggui, M. H., Azouz, M. M., Abdelli, M. N., Boudabous, M., Feki, M., Fekih, M., Mahmoudi, M., Boudabbous, M., Figuigui, M., Medhioub, M., Safer, M., Azzouz, M., Abbes, M., El Abkari, M., Aqodad, N., Azib, N., Bellil, N., Benhoumane, N., Benzoubbeir, N., Elkhabiz, N., Hemdani, N., Lahmidani, N., Abdelli, N., Ben Chaabane, N., Tahri, N., Benhoummane, N., Ben Jaafar, N., Ben Mustapha, N., Maamouri, N., Hannachi, N., Ben Alaya, N., Bibani, N., Trad, N., Elleuch, N., Kharmach, O., Bahri, O., Bousnina, O., Gharbi, O., Benjira, R., Ennaifer, R., Dabbèche, R., Jouini, R., Zgolli, R., Baklouti, R., Bouali Mohamed, R., Marouani, R., Kallel, R., Berrag, S., El Yazal, S., Jiddi, S., Mechhour, S., Morabit, S., Oubaha, S., Sentissi, S., Bouaziz, S., Soua, S., Hachicha, S., Elaboudi, S., Ajmi, S., Mallat, S., Bouchoucha, S., Mrabti, S., Ben Slama, S., Hamdi, S., Laabidi, S., Ayadi, S., Hidri, S., Bizid, S., Ben Hamida, S., Zertiti, S., Ben Amor, S., Nsibi, S., Bellakhal, S., Bahja, S., Jomni, T., Hliwa, W., Rebai, W., Ben Mansour, W., Ben Othmen, W., Dhouib, W., Hammoumi, W., Zaatour, W., Bouhlel, W., Feki, W., Triki, W., Said, Y., Zaimi, Y., Gorgi, Y., Bouhnoun, Z., Samlani, Z., Hamidi, Z., Mnif, Z., and Ben Safta, Z.

Catalog

Books, media, physical & digital resources
See catalog results